A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?

✍ Scribed by Meijun Long; Weijuan Jia; Shunrong Li; Liang Jin; Jiannan Wu; Nanyan Rao; Huiyi Feng; Kai Chen; Heran Deng; Fengtao Liu; Fengxi Su; Erwei Song

• Publisher: Springer US
• Year: 2011
• Tongue: English
• Weight: 188 KB
• Volume: 127
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-011-1455-9